Structures by: Piaskowska A.
Total: 6
4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-[3-(3-chloro-4-fluorobenzenesulfonamido)propyl]piperidin-1-ium chloride
C21H23ClF2N3O3S,Cl
Acta Crystallographica Section C (2018) 74, 11
a=5.7077(2)Å b=9.7798(3)Å c=41.2280(11)Å
α=90° β=91.123(2)° γ=90°
4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-[3-(3-methylbenzenesulfonamido)propyl]piperidin-1-ium chloride
C22H27FN3O3S,Cl
Acta Crystallographica Section C (2018) 74, 11
a=21.1233(4)Å b=6.4503(2)Å c=33.9243(9)Å
α=90° β=95.453(2)° γ=90°
4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-[4-(5-fluoro-3-methylbenzo[<i>b</i>]thiophene-2-sulfonamido)butyl]piperidin-1-ium chloride
C25H28F2N3O3S2,Cl
Acta Crystallographica Section C (2018) 74, 11
a=5.99600(10)Å b=41.1095(5)Å c=10.4904(2)Å
α=90° β=103.972(2)° γ=90°
4-(6-Fluoro-1,2-benzoxazol-3-yl)-1-[4-(6-fluorobenzo[<i>b</i>]thiophene-2-sulfonamido)butyl]piperidin-1-ium chloride
C24H26ClFN3O3S2,Cl
Acta Crystallographica Section C (2018) 74, 11
a=21.8891(3)Å b=6.95800(10)Å c=17.7899(2)Å
α=90° β=109.5580(10)° γ=90°
<i>catena</i>-poly[benzyldecyldimethylammonium [plumbate(II)-tri-μ-bromido]]
C19H34N,PbBr3
Acta Crystallographica Section C (2012) 68, 7 m173-m176
a=9.43540(10)Å b=34.7040(5)Å c=7.68730(10)Å
α=90.00° β=92.0620(10)° γ=90.00°
7-Methoxyflavanone
C16H14O3
Acta Crystallographica Section E (2013) 69, 2 o271
a=8.5600(3)Å b=6.6320(2)Å c=23.4130(7)Å
α=90.00° β=90.742(2)° γ=90.00°